Research teams who work with this compound typically focus on understanding how it behaves in cell culture models, organoid platforms, and animal studies, while carefully documenting conditions and outcomes instead of making any clinical promises
While BPC-157 is noted to have a very short half-life (less than 30 min [51, 52]), the angiogenic, anti-inflammatory, and tissue regeneration processes it initiates appear to persist for weeks to months in animal studies, far exceeding the peptides pharmacokinetic presence [19, 53]
BPC-157 interacts with signals involved in inflammation balance, angiogenesis, collagen activity, gut-barrier integrity, and local tissue response
With B12 injections, you also have to be careful not to inject them into a vein